Infectious Disease Treatment Market Estimated to Experience a Hike in Growth By 2024

Infectious diseases are the type of disorders caused by different organisms such as bacteria, virus,
fungi or parasites. The organism can be harmful or helpful to the human body and under some
conditions the organism causes different diseases. Diseases can be transferable from person to
person, bites of insects and animals, through ingestion of contaminated food or water or being
exposed to organisms in the environment. Signs and symptoms such as fever, fatigue, etc. vary
depending on the type of organism causing the infection. Mild infection can be treated through
prescribed medicines by physicians while life threatening infections may require hospitalization.
Many infectious disease such as measles and chickenpox have been controlled through vaccination
programs. Taking precautions such as creating clean environment, proper sanitization and thorough
hand-washing also helps to protect individuals from most infectious diseases.
Request Report for TOC @
Cholera infection re-entered Peru in 1996 and spread through the existing sanitation and water
systems, causing over 3,000 deaths. Seafood exports were embargoed from Peru and tourism
decreased, costing an estimated loss of at least US$ 770 Mn to the Peruvian economy in one year.
International military networks such as the U.S. Department of Defense Global Emerging Infections
System (DoD-GEIS), private clinics, individual scientists and public health practitioners are the
networks which provide the formal information sources for the spread of infectious diseases. Easy
approval from Food and Drug Administration (FDA) for drug regulation in market, and role of
major key players also plays an important role for the infectious disease treatment market.
The bacterial disease type segment is expected to witness remarkable growth in the global
infectious disease market due to the increasing evolution of different microorganisms in different
environmental conditions, unhealthy food habits among population, and increase in prevention care
facilities for patients which will address to various research, other prevention methods, and
education in order to prevent the epidemiology of infectious diseases. The parasitic disease and
viral disease segment type is expected to register significant growth through 2024 due to the
emergence of different mutation technologies and chemical utilization and upcoming research
laboratories in emerging countries.
Request To Sample of Report @
Based on treatment type, antiparasite segment is expected to contribute largest share in global
infectious disease treatment market by 2016 end owing to the evolution of different disease
indication through parasites. For instance, Zika Virus is transmitted through mosquitoes. Based on
diagnosis test type, the global infectious disease treatment market has been segmented into
laboratory test, biopsies and imaging scans. Laboratory test segment is expected to contribute the
maximum share among diagnosis test type segments. Based on the end user, hospital segment is
projected to have the largest market share among other segments due to the availability of trained
professionals, easy availability of diagnosis methods, and reimbursement policies for major
treatment procedures.
On the basis of regional presence, global infectious disease treatment market is segmented into five
key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America is expected to lead the global infectious disease treatment market due to unhealthy
food intake habits of the population, improper sanitization, new disease evolution and
environmental conditions. According to the WHO statistics for the year 2011, prevalence of
infectious disease treatment is high in developed countries such as U.S. and U.K. More precautions
are being undertaken in the MEA region due to the prevalence of various viral diseases which have
a potential to spread and create an epidemic situation for the world population.
Some of the major players in global infectious disease treatment market are Janssen Global
Services, Merck & Co., GlaxoSmithKline Pharmaceutical, Inc., Pfizer, F. Hoffmann-La Roche,
Novartis, Achillion Pharmaceuticals, Auritec Pharmaceuticals, Isis Pharmaceuticals and Gilead
Sciences. etc.
Pre Book Full Report @